Limosilactobacillus reuteri consumption significantly reduces the total cholesterol concentration without affecting other cardiovascular disease risk factors in adults: A systematic review and meta-analysis

Cholesterol lowering in diet-induced hypercholesterolemic mice using Lactobacillus bile salt hydrolases with different substrate specificities

“…Compared to the HCD + NB5462 group, YB81 induced notable alterations in CHOL metabolism-related microbes. Specifically, YB81 increased the levels of beneficial probiotics, such as L. reuteri 40,41 and L. johnsonii , 18,42 both of which are known for their therapeutic effects on hypercholesterolemia in SPF mice. Furthermore, the proportion of Atopobiaceae significantly increased in the HCD + YB81 group.…”

“…Compared to the HCD + NB5462 group, YB81 induced notable alterations in CHOL metabolism-related microbes. Specifically, YB81 increased the levels of beneficial probiotics, such as L. reuteri 40,41 and…”